BIOMAT Database Logo BIOMAT Database Logo

Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine. 1991

T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.

Various 3'-deoxy pyrimidine nucleoside analogues have been synthesized for evaluation as potential anticancer and antiviral agents. Among these compounds, 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine (10, 3'-deoxy-ara-C) and 3'-deoxycytidine (22) had significant anticancer activity against CCRF-CEM, L1210, P388, and S-180 cancer cell lines in vitro, producing ED50 values of 2, 10, 5, and 34 microM, respectively, for 3'-deoxy-ara-C (10); and 25, 5, 2.5, and 15 microM, respectively, for 3'-deoxycytidine (22). Thus, 3'-deoxy-ara-C (10) was 12.5 times more active against CCRF-CEM cells than 3'-deoxycytidine (22). The 2'-O-acetyl, 5'-O-acetyl, and 2',5'-di-O-acetyl derivatives of 3'-deoxy-ara-C (10), compounds 34, 31, and 30, demonstrated anticancer activity in the same range as 3'-deoxy-ara-C (10) against CCRF-CEM, L1210, P388, and S-180 cells. The 5'-O-acetyl derivative (31) had significantly greater activity against CCRF-CEM with an ED50 value of 0.4, but this compound also showed similar activity, as did 3'-deoxy-ara-C, against L1210, P388, and S-180 with ED50 values of 3, 3, and 13 microM, respectively. 3'-Deoxy-ara-C was also evaluated in vitro against HSV-2, HCMV, and GPCMV viruses and was found to be not very active with respective IC50 values of 110, 220, and 1000 microM. The single-crystal structure of 3'-deoxy-ara-C (10) was determined by X-ray crystallography. There are two molecules of the nucleoside and one molecule of water in the asymmetric unit. The sugar moieties of the two nucleoside molecules adopt different conformations. In molecule A, the ring pucker is C3'-endo with P = 18.7 degrees and tau m = 37.3 degrees, while the CH2OH side chain is gauche+. In molecule B, the ring pucker is C2'-endo with P = 156.8 degrees and tau m = 37.8 degrees and the side chain is trans.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
[Oligodeoxyribonucleotides containing 1-(beta-D-3'-deoxy-threo-pentofuranosyl)pyrimidine chains].
January 1994, Bioorganicheskaia khimiia,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Synthesis of 8-(3'-deoxy-alpha-D-threo-pentofuranosyl) adenine and 9-(3'-deoxy-alpha-D-threo-pentofuranosyl) adenine.
April 1975, Journal of medicinal chemistry,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
January 1999, Cancer chemotherapy and pharmacology,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Cell kill kinetics of an antineoplastic nucleoside, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytosine.
October 1996, Biochemical pharmacology,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Nucleosides. L. Synthesis of 2,3'-imino-1-(2-deoxy-beta-d-threo-pentofuranosyl)thymine and related derivatives.
April 1968, The Journal of organic chemistry,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
[Antisense oligonucleotides containing 1-(beta-D-2'-deoxy-threo-pentofuranosyl)thymine at the 3'- and 5'-end].
June 1994, Bioorganicheskaia khimiia,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106).
January 2002, Nucleic acids research. Supplement (2001),
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
August 1991, Journal of medicinal chemistry,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
3-Bromo-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine: a nucleoside which strongly enhances DNA duplex stability.
February 2005, Acta crystallographica. Section C, Crystal structure communications,
T S Lin, and J H Yang, and M C Liu, and Z Y Shen, and Y C Cheng, and W H Prusoff, and G I Birnbaum, and J Giziewicz, and I Ghazzouli, and V Brankovan
Nucleosides. XIV. Synthesis of 3'-deoxyadenosine and 9-(3-deoxy- -L-threo-pentofuranosyl)adenine.
December 1971, The Journal of organic chemistry,
Copied contents to your clipboard!